SonoScape Medical Corp (300633) - Total Assets
Based on the latest financial reports, SonoScape Medical Corp (300633) holds total assets worth CN¥4.30 Billion CNY (≈ $629.09 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
SonoScape Medical Corp - Total Assets Trend (2012–2025)
This chart illustrates how SonoScape Medical Corp's total assets have evolved over time, based on quarterly financial data. Also see 300633 market cap for the company's overall valuation and market capitalisation.
SonoScape Medical Corp - Asset Composition Analysis
Current Asset Composition (December 2025)
SonoScape Medical Corp's total assets of CN¥4.30 Billion consist of 63.9% current assets and 36.1% non-current assets. Review 300633 total liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 32.4% |
| Accounts Receivable | CN¥300.53 Million | 6.8% |
| Inventory | CN¥763.60 Million | 17.3% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥145.07 Million | 3.3% |
| Goodwill | CN¥108.70 Million | 2.5% |
Asset Composition Trend (2012–2025)
This chart illustrates how SonoScape Medical Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See latest SonoScape Medical Corp stock price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: SonoScape Medical Corp's current assets represent 63.9% of total assets in 2025, a decrease from 67.0% in 2012.
- Cash Position: Cash and equivalents constituted 32.4% of total assets in 2025, up from 14.1% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 5.0% of total assets, a decrease from 26.0% in 2012.
- Asset Diversification: The largest asset category is inventory at 17.3% of total assets.
SonoScape Medical Corp Competitors by Total Assets
Key competitors of SonoScape Medical Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Demant A/S
CO:DEMANT
|
Denmark | Dkr39.07 Billion |
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Vitrolife AB
ST:VITR
|
Sweden | Skr11.30 Billion |
|
Tellgen Corp
SHE:300642
|
China | CN¥2.01 Billion |
|
Imricor Medical Systems Inc
AU:IMR
|
Australia | AU$45.79 Million |
|
Hironic Co. Ltd
KQ:149980
|
Korea | ₩80.01 Billion |
|
Atomo Diagnostics Ltd
AU:AT1
|
Australia | AU$9.48 Million |
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
SonoScape Medical Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.96 | 3.53 | 2.40 |
| Quick Ratio | 1.97 | 2.51 | 1.62 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥1.79 Billion | CN¥1.90 Billion | CN¥753.10 Million |
SonoScape Medical Corp - Advanced Valuation Insights
This section examines the relationship between SonoScape Medical Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.23 |
| Latest Market Cap to Assets Ratio | 0.28 |
| Asset Growth Rate (YoY) | 2.2% |
| Total Assets | CN¥4.41 Billion |
| Market Capitalization | $1.22 Billion USD |
Valuation Analysis
Below Book Valuation: The market values SonoScape Medical Corp's assets below their book value (0.28x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: SonoScape Medical Corp's assets grew by 2.2% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for SonoScape Medical Corp (2012–2025)
The table below shows the annual total assets of SonoScape Medical Corp from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥4.41 Billion ≈ $644.78 Million |
+2.16% |
| 2024-12-31 | CN¥4.31 Billion ≈ $631.13 Million |
+14.36% |
| 2023-12-31 | CN¥3.77 Billion ≈ $551.88 Million |
+6.41% |
| 2022-12-31 | CN¥3.54 Billion ≈ $518.63 Million |
+17.34% |
| 2021-12-31 | CN¥3.02 Billion ≈ $441.97 Million |
+34.12% |
| 2020-12-31 | CN¥2.25 Billion ≈ $329.53 Million |
-6.73% |
| 2019-12-31 | CN¥2.41 Billion ≈ $353.30 Million |
+31.53% |
| 2018-12-31 | CN¥1.84 Billion ≈ $268.61 Million |
+37.47% |
| 2017-12-31 | CN¥1.34 Billion ≈ $195.40 Million |
+31.36% |
| 2016-12-31 | CN¥1.02 Billion ≈ $148.75 Million |
+8.64% |
| 2015-12-31 | CN¥935.73 Million ≈ $136.93 Million |
+9.02% |
| 2014-12-31 | CN¥858.30 Million ≈ $125.60 Million |
+37.16% |
| 2013-12-31 | CN¥625.75 Million ≈ $91.57 Million |
+0.70% |
| 2012-12-31 | CN¥621.41 Million ≈ $90.93 Million |
-- |
About SonoScape Medical Corp
SonoScape Medical Corp., together with its subsidiaries, engages in the research, development, production, and sale of medical diagnosis and treatment equipment in China and internationally. It offers ultrasound medical imaging products comprising trolley and portable color dopplers, B/W ultrasounds, and transducers; endoscopic diagnosis and treatment products consisting of image processors, ligh… Read more